RxDoctor Payments Data

Uzma Samadani, MD

Neurological Surgery · Golden Valley, MNNPI 1407916703

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 70.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $11,705 and has fallen 97.5% since, to $288 in 2025.

$20,123in general payments, 2019–2025

Across 67 payments — averaging $300.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$14K
  • Medtronic$5K
  • Abbott$740
  • Derma Sciences, Inc.$148
  • Nevro Corp.$127
  • Zimvie Inc.$123
  • plus $176 from 5 others

What the payments were for

  • Consulting fees$6,50032%
  • Speaking & faculty fees$7,50037%
  • Travel & lodging$2,79914%
  • Food & beverage$3,32417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation8$14,181
Medtronic(2 entities)43$4,629
Abbott8$740
Derma Sciences, Inc.1$148
Nevro Corp.1$127
Zimvie Inc.1$123
Spineguard, Inc.1$107
Boston Scientific1$23
Acadia Pharmaceuticals Inc1$18
Stryker1$15
Catalyst Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,123 in reported general payments places this provider in the 85th percentile of 140 neurological surgery providers in Minnesota.

See all neurological surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$99,228
Medicare patients
54
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl56$432
Cyclobenzaprine Hcl16$104

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Golden Valley

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →